| 000 | 01685 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513091827.0 | ||
| 264 | 0 | _c19960807 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199608013350503 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFekade, D | |
| 245 | 0 | 0 |
_aPrevention of Jarisch-Herxheimer reactions by treatment with antibodies against tumor necrosis factor alpha. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cAug 1996 |
||
| 300 |
_a311-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFever _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadverse effects |
| 650 | 0 | 4 |
_aInflammation _xchemically induced |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aInterleukin-8 _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPenicillins _xadverse effects |
| 650 | 0 | 4 |
_aRelapsing Fever _xblood |
| 650 | 0 | 4 | _aSheep |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xanalysis |
| 700 | 1 | _aKnox, K | |
| 700 | 1 | _aHussein, K | |
| 700 | 1 | _aMelka, A | |
| 700 | 1 | _aLalloo, D G | |
| 700 | 1 | _aCoxon, R E | |
| 700 | 1 | _aWarrell, D A | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 335 _gno. 5 _gp. 311-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199608013350503 _zAvailable from publisher's website |
| 999 |
_c8662191 _d8662191 |
||